SITC Cancer Immunotherapy CONNECT


2018 Fellowships

Submission Period Closes:
Tuesday, February 20, 2018 at 5 p.m. EST

*Must be a SITC member to apply.

Learn More


New on SITC connectED: Understanding Cancer Immunotherapy – Online Activity

Designed for patients and caregivers, this interactive activity takes a closer look at the potential side effects of cancer immunotherapy. Based on the Patient Resource Guide, Understanding Cancer Immunotherapy 3rd Edition, this activity explains side effects that patients may experience while receiving cancer immunotherapy treatment and how to manage these side effects.

Register for the Class


Learn the Value of 

member-ribbon-v4.pngSee members discuss the benefits of a SITC membership in the society's new video.

Watch The Video


New on The Sentinel

Check out the latest content on The Sentinel, SITC's official blog:


Learn Basic Principles of Cancer Immunotherapy

Ensure your patients are receiving all of their cancer care options. Register for an upcoming Advances in Cancer Immunotherapy™ (ACI) program for one of the following cities:

Feb. 9 in Durham, NCFeb. 24 in Charleston, SCMarch 3 in Dallas, TXMarch 10 in Miami, FLMarch 24 in Buffalo, NY

Register for an ACI PROGRAM


Access Scientific Highlights and More from the 32nd Annual Meeting

Review SITC's coverage from National Harbor, Md. for the 32nd Annual Meeting, visit The Sentinel, SITC's official blog, to read scientific highlights, view daily photo galleries and much more.

Read SITC 2017 Coverage


Learn About the Awarded Projects of the SITC Sparkathon

Projects of the 2017 SITC Sparkathon have been announced! Learn more about teams TimIOs and the METIOR Incubator, and see how you can support and become involved in the efforts of these talented young investigators.



The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • The majority of NSCLC patients do not still respond to PD-1/PD-L1 treatment. Chemotherapy is theorized to increase the release of tumor antigen resulting in increased response with immunotherapy. But cytotoxic chemotherapy can also destroy actively proliferating ...

  • more details in our latest news story:   ------------------------------ Jade Parker Editor Future Science Group ------------------------------

  • Course Name: 6 th Annual Lung Cancer Symposium Course Date: Friday, March 2, 2018 Course Co-Directors and Planners : Ralph Zinner, MD; Gregory Kane, MD; Judith Alberto, RPh; Rita Axelrod, MD; Stephanie Bork, MSN, CRNP; Nathaniel R. Evans III, ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More